l-carnitine tmao koeth 2013 nature medicine γ–Butyrobetaine is a pro-atherogenic intermediate in gut microbial metabolism of to Effects of choline metabolite—trimethylamine N-oxide
Effects of choline metabolitetrimethylamine N oxide on immunometabolism in inflammatory bowel disease Frontiers Frontiers Impacts of intestinal microbiota metabolite trimethylamine N oxide on cardiovascular disease: a bibliometric analysis Butyrobetaine Is a Proatherogenic Intermediate in Gut Microbial Metabolism of L Carnitine to TMAO: Cell Metabolism Meat metabolizing bacteria in atherosclerosis Nature Medicine Frontiers TMAO as a potential biomarker and therapeutic target for chronic kidney disease: A review The gutbrain axis and trimethylamine N oxide: an emergent biomarker in neurological diseases ScienceDirect
Pay in 4 interest-free payments of $6.02 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 20 - Sep 25





